Original Research
Published on 19 Feb 2021
Molecular Subtype May Be More Associated With Prognosis and Chemotherapy Benefit Than Tumor Size in T1N0 Breast Cancer Patients: An Analysis of 2,168 Patients for Possible De-Escalation Treatment
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.636266
- 3,987 views
- 5 citations
